Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid ...
Q3 2026
Feb 12, 2026
Q2 2026
Nov 13, 2025
Q1 2026
Aug 12, 2025
FY 2025
Jun 23, 2025
Q4 2025